These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6371845)

  • 1. Progestins can mimic, inhibit and potentiate the actions of androgens.
    Bardin CW; Brown T; Isomaa VV; Jänne OA
    Pharmacol Ther; 1983; 23(3):443-59. PubMed ID: 6371845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of progestins on submaxillary gland epidermal growth factor: demonstration of androgenic, synandrogenic and antiandrogenic actions.
    Bullock LP; Barthe PL; Mowszowicz I; Orth DN; Bardin CW
    Endocrinology; 1975 Jul; 97(1):189-95. PubMed ID: 1140168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency.
    Lemus AE; Enríquez J; García GA; Grillasca I; Pérez-Palacios G
    J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):121-9. PubMed ID: 9182866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgenic, synandrogenic, and antiandrogenic actions of progestins.
    Bullock LP; Bardin CW
    Ann N Y Acad Sci; 1977 Mar; 286():321-30. PubMed ID: 281183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid receptors and hormone action: physiological and synthetic androgens and progestins can mediate inappropriate biological effects.
    Jänne OA; Bardin CW
    Pharmacol Rev; 1984 Jun; 36(2 Suppl):35S-42S. PubMed ID: 6382356
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgenic action of progestins and possible synandrogenic properties of antiandrogens used in oral contraceptives.
    Spona J
    Gynecol Obstet Invest; 1984; 17(2):66-72. PubMed ID: 6706245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen and progestin stimulation of ornithine decarboxylase activity in the mouse kidney.
    Bullock LP
    Endocrinology; 1983 Jun; 112(6):1903-9. PubMed ID: 6682754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo metabolism and binding of 6 alpha-methylprogesterone; a progestin with anti-androgenic and synandrogenic activities.
    Brown TR; Bullock LP; Bardin CW
    Adv Exp Med Biol; 1979; 117():269-80. PubMed ID: 474281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of pharmaceutical compounds on male fertility.
    Neumann F; Diallo FA; Hasan SH; Schenck B; Traore I
    Andrologia; 1976; 8(3):203-35. PubMed ID: 793446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgenic, antiandrogenic, and synandrogenic actions of progestins: role of steric and allosteric interactions with androgen receptors.
    Bullock LP; Bardin CW; Sherman MR
    Endocrinology; 1978 Nov; 103(5):1768-82. PubMed ID: 748017
    [No Abstract]   [Full Text] [Related]  

  • 11. The cellular mechanism of the antiandrogenic action of nomegestrol acetate, a new 19-nor progestagen, on the rat prostate.
    Botella J; Paris J; Lahlou B
    Acta Endocrinol (Copenh); 1987 Aug; 115(4):544-50. PubMed ID: 3630545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of androgen regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase gene expression in rodent kidney and accessory sex organs.
    Crozat A; Palvimo JJ; Julkunen M; Jänne OA
    Endocrinology; 1992 Mar; 130(3):1131-44. PubMed ID: 1537280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay.
    McRobb L; Handelsman DJ; Kazlauskas R; Wilkinson S; McLeod MD; Heather AK
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):39-47. PubMed ID: 18395441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a nonsteroidal antiandrogen, flutamide, on androgen receptor dynamics and ornithine decarboxylase gene expression in mouse kidney.
    Kontula KK; Seppänen PJ; van Duyne P; Bardin CW; Jänne OA
    Endocrinology; 1985 Jan; 116(1):226-33. PubMed ID: 3964747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A).
    Africander DJ; Storbeck KH; Hapgood JP
    J Steroid Biochem Mol Biol; 2014 Sep; 143():404-15. PubMed ID: 24861265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synandrogenic and antiandrogenic effect of progestins: comparison with nonprogestational antiandrogens.
    Mowszowicz I; Bieber DE; Chung KW; Bullock LP; Bardin CW
    Endocrinology; 1974 Dec; 95(6):1589-99. PubMed ID: 4373227
    [No Abstract]   [Full Text] [Related]  

  • 17. Further studies on the androgenic, anti-androgenic, and synandrogenic actions of progestins.
    Gupta C; Bullock LP; Bardin CW
    Endocrinology; 1978 Mar; 102(3):736-44. PubMed ID: 743990
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterisation of gene expression patterns in 22RV1 cells for determination of environmental androgenic/antiandrogenic compounds.
    Hartel A; Didier A; Pfaffl MW; Meyer HH
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):231-8. PubMed ID: 12711008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
    Phillips A; Hahn DW; McGuire JL
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1191-6. PubMed ID: 1415445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ornithine decarboxylase mRNA in mouse kidney: a low abundancy gene product regulated by androgens with rapid kinetics.
    Jänne OA; Kontula KK; Isomaa VV; Bardin CW
    Ann N Y Acad Sci; 1984; 438():72-84. PubMed ID: 6598355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.